GlassScriptPhysician profile
Mircea Petrina
NPI 1861624009
$8,239.57
in general payments reported to CMS, 2019-2025
34 companies · $17.37 in 2025
The $17.37 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,937 · 2020: $64.33 · 2021: $305 · 2022: $1,093 · 2023: $1,188 · 2024: $636 · 2025: $17.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,828 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,827.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,441.58 | 2019-2024 | Jot Dx |
| Medtronic Vascular, INC. | $1,972.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $465.57 | 2019-2024 | Camzyos, Eliquis |
| Medtronic, INC. | $270.24 | 2022-2023 | Onyx Frontier |
| Bayer Healthcare Pharmaceuticals INC. | $245.34 | 2023 | |
| Novartis Pharmaceuticals Corporation | $225.72 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.75 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $211.09 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.84 | 2019-2024 | Jardiance |
| Impulse Dynamics (USA) INC. | $201.95 | 2023 | Optimizer |
| Heartflow, INC. | $186.39 | 2022-2024 | Ffrct |
| Amgen INC. | $184.95 | 2019-2022 | |
| Pfizer INC. | $180.08 | 2019-2023 | |
| Kiniksa Pharmaceuticals, LTD. | $176.79 | 2021-2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $158.66 | 2020-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $151.10 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $135.34 | 2024 | Wainua |
| Penumbra, INC. | $99.24 | 2019 | |
| Shockwave Medical, INC | $75.30 | 2022 | |
| Ge Healthcare | $59.57 | 2019 | |
| Esperion Therapeutics, INC. | $54.07 | 2021-2022 | |
| Novo Nordisk INC | $49.68 | 2023-2024 | Wegovy, Ozempic |
| Abiomed | $31.73 | 2024 | Impella |
| Cardiovascular Systems INC. | $31.49 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $30.64 | 2019-2021 | |
| Abbvie INC. | $26.39 | 2023 | |
| Baxter Healthcare | $23.44 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $22.39 | 2024 | (5091) Amb Mon & Diag Und |
| Astellas Pharma US INC | $21.79 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $18.82 | 2024 | |
| Inspire Medical Systems, INC. | $17.38 | 2023 | Inspire |
| Bardy Diagnostics, INC. | $15.87 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $13.72 | 2019 | |
| Medicure Pharma INC. | $13.34 | 2024 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mircea Petrina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.